Shuichiro Yamanaka

Dr. Shuichiro Yamanaka

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2020 in Cell Reports
Verified
Journal Article
Open access
TFToshinari Fujimoto
Toshinari Fujimoto
SYShuichiro Yamanaka
Shuichiro Yamanaka
STSusumu Tajiri
Susumu Tajiri
TTTsuyoshi Takamura
Tsuyoshi Takamura
YSYatsumu Saito
Yatsumu Saito
TYTakashi Yokoo
Takashi Yokoo
Animal fetuses may be used for the regeneration of human organs. We have previously generated a transgenic mouse model that allows diphtheria toxin (DT)-induced ablation of Six2-positive nephron progenitor cells (NPCs). Elimination of existing native host NPCs enables their replacement with donor NPCs, which can generate neo-nephrons. However, this system cannot be applied to human NPCs, because DT induces apoptosis in human cells. Therefore, the present study presents a transgenic mouse model for the ablation of NPCs using tamoxifen, which does not affect human cells. Using this system, we successfully regenerate interspecies neo-nephrons, which exhibit urine-producing abilities, from transplanted rat NPCs in a mouse host. Transplantation of human induced pluripotent stem cell (iPSC)-derived NPCs results in differentiation into renal vesicles, which connect to the ureteric bud of the host. Thus, we demonstrate the possibility of the regeneration of human kidneys derived from human iPSC-derived NPCs via NPC replacement.

6 August 2020 in Xenotransplantation
Verified
Journal Article
Closed access
PDF file
TYTakashi Yokoo
Takashi Yokoo
SYShuichiro Yamanaka
Shuichiro Yamanaka
EKEiji Kobayashi
Eiji Kobayashi

1 December 2019 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
YSYatsumu Saito
Yatsumu Saito
SYShuichiro Yamanaka
Shuichiro Yamanaka
TFToshinari Fujimoto
Toshinari Fujimoto
STSusumu Tajiri
Susumu Tajiri
NMNaoto Matsumoto
Naoto Matsumoto
TYTakashi Yokoo
Takashi Yokoo

26 November 2012 in Journal of Biomedicine and Biotechnology
Verified
Journal Article
Open access
PDF file
SYShinya Yokote
Shinya Yokote
SYShuichiro Yamanaka
Shuichiro Yamanaka
TYTakashi Yokoo
Takashi Yokoo
Recent studies have reported on techniques to mobilize and activate endogenous stem-cells in injured kidneys or to introduce exogenous stem cells for tissue repair. Despite many recent advantages in renal regenerative therapy, chronic kidney disease (CKD) remains a major cause of morbidity and mortality and the number of CKD patients has been increasing. When the sophisticated structure of the kidneys is totally disrupted by end stage renal disease (ESRD), traditional stem cell-based therapy is unable to completely regenerate the damaged tissue. This suggests that whole organ regeneration may be a promising therapeutic approach to alleviate patients with uncured CKD. We summarize here the potential of stem-cell-based therapy for injured tissue repair andde novowhole kidney regeneration. In addition, we describe the hurdles that must be overcome and possible applications of this approach in kidney regeneration.

8 October 2024 in Communications Biology
Verified
Journal Article
Open access
PDF file
KFKoki Fujimori
Koki Fujimori
SYShuichiro Yamanaka
Shuichiro Yamanaka
KSKentaro Shimada
Kentaro Shimada
KMKenji Matsui
Kenji Matsui
SKShiho Kawagoe
Shiho Kawagoe
TYTakashi Yokoo
Takashi Yokoo
Porcine organs and human induced pluripotent stem cell (iPSC)-derived organoids as alternative organs for human transplantation have garnered attention, but both face technical challenges. Interspecies chimeric organ production using human iPSCs shows promise in overcoming these challenges. Our group successfully generated chimeric renal organoids using human iPSC-derived nephron progenitor cells (NPCs) and fetal mouse kidneys. However, the current technology is limited to rodents. Therefore, this study focused on producing human-pig chimeric renal organoids, as pigs are the most promising species for xenotransplantation. Modification of existing culture systems enables continuous renal development in both species, resulting in the successful creation of human-pig chimeric renal organoids. Moreover, this method can be applied to generate humanized xenogeneic kidneys for future clinical applications. This study provides evidence that optimizing culture conditions enables the early-stage kidney development beyond species barriers, thus laying the foundation for accelerating research on humanized xenogeneic kidney fabrication for clinical purposes.

15 March 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
KMKenji Matsui
Kenji Matsui
YKYoshitaka Kinoshita
Yoshitaka Kinoshita
YIYuka Inage
Yuka Inage
NMNaoto Matsumoto
Naoto Matsumoto
KMKeita Morimoto
Keita Morimoto
TYTakashi Yokoo
Takashi Yokoo
Kidney xenotransplantation has been attracting attention as a treatment option for end-stage renal disease. Fetal porcine kidneys are particularly promising grafts because they can reduce rejection through vascularization from host vessels. We are proposing xenogeneic regenerative medicine using fetal porcine kidneys injected with human nephron progenitor cells. For clinical application, it is desirable to establish reliable methods for the preservation and quality assessment of grafts. We evaluated the differentiation potency of vitrified porcine fetal kidneys compared with nonfrozen kidneys, using an in vivo differentiation model. Fetal porcine kidneys connected to the bladder were frozen via vitrification and stored in liquid nitrogen. Several days later, they were thawed and transplanted under the retroperitoneum of immunocompromised mice. After 14 days, the frozen kidneys grew and differentiated into mature nephrons, and the findings were comparable to those of nonfrozen kidneys. In conclusion, we demonstrated that the differentiation potency of vitrified fetal porcine kidneys could be evaluated using this model, thereby providing a practical protocol to assess the quality of individual lots.